# Nordic Pancreatic Cancer Trial (NorPACT) - 1

> **NCT02919787** · PHASE2,PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Oslo University Hospital** · enrollment: 140 (estimated)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **DRUG:** 5-FU
- **DRUG:** Oxaliplatine
- **DRUG:** Irinotecan
- **PROCEDURE:** Pancreatic surgery
- **DRUG:** 5-FU
- **DRUG:** Oxaliplatine
- **DRUG:** Irinotecan

## Key facts

- **NCT ID:** NCT02919787
- **Lead sponsor:** Oslo University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2016-09
- **Primary completion:** 2022-12-22
- **Final completion:** 2026-04-30
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2024-11-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02919787

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02919787, "Nordic Pancreatic Cancer Trial (NorPACT) - 1". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02919787. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*